Direxion Daily S&P Biotech Bull 3X Shares · $624M$1,931
LABULABU vsIVVIVViShares Core S&P 500 ETF · $887B$17,151
$10,000 five years ago, dividends reinvested · they hold 1.6% in common
LABUMeasureIVV
Returns · dividends reinvested
+30.9%Year to dateJan 1 → Nov 5+8.4%
+81.9%1 yearTotal return+9.7%
+57.4%3 years · per year$10,000 became $38,980 · $18,221+22.1%
−28.0%5 years · per year$10,000 became $1,931 · $17,151+11.4%
Cost and income
0.96%Expense ratio$96 · $3 a year on $10k · lower is better0.03%
0.44%Trailing 12-mo yield$44 · $114 a year on $10k1.14%
Risk · past year
−41.8%Worst dropSmaller is better−8.9%
89.2%VolatilityLower is calmer13.6%
LABUIVV Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5IVV wins
End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns